Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Year study tracks young breast cancer patients to uncover hidden patterns

NCT ID NCT01468246

Knowledge-focused Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 1,300 women aged 40 or younger who were recently diagnosed with breast cancer. Researchers collect surveys, blood samples, and tumor tissue to learn about the disease, treatment side effects, and emotional challenges like fertility and menopause. The goal is to better understand what young women with breast cancer go through and find ways to improve their care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,302 people

The number who actually took part.

Start date

Nov 2006

Expected to finish

Jan 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study includes women who are newly-diagnosed with breast cancer. They must be 40 or younger at their diagnosis.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female * Diagnosis of breast cancer * Age 40 or younger at diagnosis * Informed consent obtained from patient * Ability to understand written and spoken English to the extent necessary to complete the questionnaires Exclusion Criteria: * Inability to understand written and spoken English to the extent necessary to complete the questionnaires * Absence of informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Beth-Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • Cape Cod Hospital

    Hyannis, Massachusetts, 02601, United States

  • DF/BWCC at Milford Regional Medical Center

    Milford, Massachusetts, 01757, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Dana-Farber/New Hampshire Oncology-Hematology

    Londonderry, New Hampshire, 03053, United States

  • Lowell General Hospital

    Lowell, Massachusetts, 01854, United States

  • MGH/North Shore Cancer Center

    Danvers, Massachusetts, 01923, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02215, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Newton-Wellesley Hospital

    Newton, Massachusetts, 02462, United States

  • South Shore Hospital

    South Weymouth, Massachusetts, 02190, United States

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, 3M5, Canada

  • University of Colorado Cancer Center

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.